Pomalyst (pomalidomide) is a prescription drug that’s used to treat multiple myeloma in adults ... Pomalyst is not chemotherapy. It is a type of immunotherapy called an immunomodulating agent.

Multiple myeloma (MM), which is caused by the transformation ... Traditional therapies include chemotherapy, steroids and stem-cell transplantation, which typically result in median survival ...

Multiple myeloma is currently not curable, but we can manage the disease effectively for years. For active myeloma, treatment may include chemotherapy, proteasome inhibitors, immune-modifying drugs or ...

S Lional is supported by the Richard and Annelly Deets Fund for Multiple Myeloma and acts as a consultant ... Sequential therapy refers to treatment with drug regimens administered one after ...

2 Today, treatment for multiple myeloma often involves an intensive combination of chemotherapy, steroids, immunomodulatory drugs, and bone marrow transplants to slow down this multiplication and ...

So, we now have multiple new classes of drugs, multiple agents that are FDA-approved for the treatment of multiple myeloma, more than 15, 16 different drugs that have become available in that period.

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

Specialists of Samara State Medical University (SamSMU) together with the pharmaceutical company Euroservice plan to develop a drug for the treatment of multiple myeloma using natural cord blood ...

Multiple Genetic Abnormalities Lead to Poor Prognosis Around 5900 people are diagnosed with myeloma each year in the UK. Standard treatments include targeted drugs, chemotherapy, and stem cell ...